Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Clinical trial NCT05715931 · RECRUITING

Trial details

NCT number: NCT05715931
Sponsor: Yu jiren
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Stomach Adenocarcinoma of Esophagogastric Junction HER2-positive Gastric Cancer

Start date: 2023-02-28
Primary completion: 2025-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.